Summit Hotel Properties (NYSE:INN – Get Free Report) updated its FY 2024 earnings guidance on Monday. The company provided earnings per share guidance of 0.920-0.980 for the period, compared to the consensus earnings per share estimate of 0.940. The company issued revenue guidance of -.
Summit Hotel Properties Price Performance
NYSE:INN traded up $0.07 during trading hours on Monday, reaching $6.18. 686,530 shares of the company were exchanged, compared to its average volume of 751,201. The company has a market capitalization of $669.52 million, a P/E ratio of -56.64 and a beta of 2.05. The company has a debt-to-equity ratio of 0.99, a current ratio of 0.89 and a quick ratio of 0.89. The business has a 50 day moving average of $6.61 and a 200 day moving average of $6.27. Summit Hotel Properties has a 1-year low of $5.66 and a 1-year high of $7.22.
Summit Hotel Properties Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, November 29th. Investors of record on Friday, November 15th will be paid a $0.08 dividend. This represents a $0.32 dividend on an annualized basis and a yield of 5.18%. The ex-dividend date of this dividend is Friday, November 15th. Summit Hotel Properties’s dividend payout ratio (DPR) is presently -290.91%.
Summit Hotel Properties Company Profile
Summit Hotel Properties, Inc is a publicly traded real estate investment trust focused on owning premium-branded lodging properties with efficient operating models primarily in the upscale segment of the lodging industry. As of November 1, 2023, the Company’s portfolio consisted of 101 assets, 57 of which are wholly owned, with a total of 15,035 guestrooms located in 24 states.
Further Reading
- Five stocks we like better than Summit Hotel Properties
- Are Penny Stocks a Good Fit for Your Portfolio?
- Intel: Is Now the Time to Be Brave?Â
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Investing in Commodities: What Are They? How to Invest in Them
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Summit Hotel Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Summit Hotel Properties and related companies with MarketBeat.com's FREE daily email newsletter.